These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15099274)

  • 1. A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants.
    Pengo V; Biasiolo A; Pegoraro C; Iliceto S
    J Thromb Haemost; 2004 May; 2(5):702-7. PubMed ID: 15099274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M; Finazzi G; Bevers EM; Barbui T
    Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
    Pengo V; Balestrieri G; Tincani A; Spatola L; Biasiolo A; Brocco T
    Thromb Haemost; 1997 Jan; 77(1):123-6. PubMed ID: 9031461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V; Biasiolo A; Rampazzo P; Brocco T
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional coagulation test to identify anti-beta2-glycoprotein I dependent lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 119(6):753-9. PubMed ID: 16842842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J; Meijer P; Vermylen J
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of silica clotting time for detection of lupus anticoagulants].
    Lee HR; Kim JE; Ha SH; Kim HK; Park S; Cho HI
    Korean J Lab Med; 2009 Dec; 29(6):497-504. PubMed ID: 20046079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
    Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procoagulant effect of anti-beta2-glycoprotein I antibodies with lupus anticoagulant activity.
    Pengo V; Brocco T; Biasiolo A; Rampazzo P; Carraro P; Zamarchi R
    Blood; 1999 Dec; 94(11):3814-9. PubMed ID: 10572096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
    Lambert M; Ferrard-Sasson G; Dubucquoi S; Hachulla E; Prin L; Hatron PY; Goudemand J; Boffa MC; Caron C
    Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C.
    Galli M; Ruggeri L; Barbui T
    Blood; 1998 Mar; 91(6):1999-2004. PubMed ID: 9490682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dilute prothrombin time-based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin.
    Liestøl S; Jacobsen EM; Wisløff F
    Thromb Res; 2002 Jan; 105(2):177-82. PubMed ID: 11958810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing.
    Genzen JR; Miller JL
    Am J Clin Pathol; 2005 Oct; 124(4):586-93. PubMed ID: 16146819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus-anticoagulant testing at NOAC trough levels.
    Ratzinger F; Lang M; Belik S; Jilma-Stohlawetz P; Schmetterer KG; Haslacher H; Perkmann T; Quehenberger P
    Thromb Haemost; 2016 Aug; 116(2):235-40. PubMed ID: 27075441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant activity of an anti-beta 2-glycoprotein I antibody is dependent on the presence of beta 2-glycoprotein I.
    Matsuda J; Gohchi K; Tsukamoto M; Saitoh N; Asami K; Hashimoto M
    Am J Hematol; 1993 Nov; 44(3):187-91. PubMed ID: 8213768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines.
    Swadzba J; Iwaniec T; Pulka M; De Laat B; De Groot PG; Musial J
    J Thromb Haemost; 2011 Sep; 9(9):1776-83. PubMed ID: 21707912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I.
    Oosting JD; Derksen RH; Entjes HT; Bouma BN; de Groot PG
    Thromb Haemost; 1992 May; 67(5):499-502. PubMed ID: 1519207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.